NUVB
Nuvation Bio Inc
Price:  
2.16 
USD
Volume:  
1,769,228.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NUVB Intrinsic Value

-2,216.30 %
Upside

What is the intrinsic value of NUVB?

As of 2025-04-29, the Intrinsic Value of Nuvation Bio Inc (NUVB) is (45.71) USD. This NUVB valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 2.16 USD, the upside of Nuvation Bio Inc is -2,216.30%.

The range of the Intrinsic Value is (122.26) - (28.94) USD

Is NUVB undervalued or overvalued?

Based on its market price of 2.16 USD and our intrinsic valuation, Nuvation Bio Inc (NUVB) is overvalued by 2,216.30%.

Note: result may not be accurate due to the invalid valuation result of DCF model.

2.16 USD
Stock Price
(45.71) USD
Intrinsic Value
Intrinsic Value Details

NUVB Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (122.26) - (28.94) (45.71) -2216.3%
DCF (Growth 10y) (30.06) - (116.09) (45.63) -2212.5%
DCF (EBITDA 5y) (18.04) - (31.06) (1,234.50) -123450.0%
DCF (EBITDA 10y) (21.12) - (34.42) (1,234.50) -123450.0%
Fair Value -8.36 - -8.36 -8.36 -487.04%
P/E (27.62) - (30.10) (29.59) -1470.1%
EV/EBITDA (6.17) - (7.53) (6.53) -402.2%
EPV (3.32) - (4.36) (3.84) -277.8%
DDM - Stable (23.54) - (138.05) (80.79) -3840.5%
DDM - Multi (20.61) - (94.62) (33.92) -1670.5%

NUVB Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 733.69
Beta 1.66
Outstanding shares (mil) 339.67
Enterprise Value (mil) 704.25
Market risk premium 4.60%
Cost of Equity 7.03%
Cost of Debt 7.00%
WACC 7.02%